Investing.com - Amarin (NASDAQ:AMRN) reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Amarin announced earnings per share of $0.04 on revenue of $167.3M. Analysts polled by Investing.com anticipated EPS of $-0.0161 on revenue of $165.71M.
Amarin shares are up 49.28% from the beginning of the year, still down 59.44% from its 52 week high of $18.00 set on February 25, 2020. They are outperforming the Nasdaq which is up 5.51% from the start of the year.
Amarin follows other major Healthcare sector earnings this month
Amarin's report follows an earnings missed by Roche Holding ADR on February 1, who reported EPS of $1.21 on revenue of $15.88B, compared to forecasts EPS of $1.28 on revenue of $16.45B.
Abbott Labs had beat expectations on January 27 with fourth quarter EPS of $1.45 on revenue of $10.7B, compared to forecast for EPS of $1.35 on revenue of $9.94B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar